The recent challenges in global chains have highlighted the necessity of securing essential medications like Ivermectin. Dependence on overseas manufacturers exposes regions to potential vulnerabilities, including delivery delays, expense fluctuations, and even political concerns. Shifting towards domestic sourcing of Ivermectin offers a multitude